1. The Molecular Context of Oxidant Stress Response in Cancer Establishes ALDH1A1 as a Critical Target: What This Means for Acute Myeloid Leukemia
    Garrett M. Dancik et al, 2023, International Journal of Molecular Sciences CrossRef
  2. Reciprocal relationship between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and therapeutic strategies
    Guiqing Ding et al, 2024, Future Oncology CrossRef
  3. ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
    Yaolu Wei et al, 2022, Frontiers in Oncology CrossRef
  4. Anti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium
    Valerio Ciccone et al, 2022, International Journal of Molecular Sciences CrossRef
  5. Optimization of an Ex-Vivo Human Skin/Vein Model for Long-Term Wound Healing Studies. Ground Preparatory Activities for the ‘Suture in Space’ Experiment Onboard the International Space Station
    Francesca Cialdai et al, 2022, International Journal of Molecular Sciences CrossRef
  6. The Nitric Oxide Donor [Zn(PipNONO)Cl] Exhibits Antitumor Activity through Inhibition of Epithelial and Endothelial Mesenchymal Transitions
    Valerio Ciccone et al, 2022, Cancers CrossRef
  7. Erucin, a natural isothiocyanate, exerts pro‐angiogenic properties in cultured endothelial cells and reverts angiogenic impairment induced by high glucose
    Shirley Genah et al, 2024, Phytotherapy Research CrossRef
  8. ALDEFLUOR activity, ALDH isoforms, and their clinical significance in cancers
    Jiang-Jie Duan et al, 2023, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
  9. Uncovering Knowledge Gaps in the Safety Profile of Antiangiogenic Drugs in Cancer Patients: Insights from Spontaneous Reporting Systems Studies
    Valerio Ciccone et al, 2023, Pharmaceuticals CrossRef